Cargando…

Identification and validation of chemokine system-related genes in idiopathic pulmonary fibrosis

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a chronic progressive interstitial lung disease with limited therapeutic options. Recent studies have demonstrated that chemokines play a vital role in IPF pathogenesis. In the present study, we explored whether the gene signature associated with ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Tianming, Wu, Xu, Zhao, Xuelei, Yao, Kecheng, Li, Xiaojuan, Ni, Jixiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140527/
https://www.ncbi.nlm.nih.gov/pubmed/37122736
http://dx.doi.org/10.3389/fimmu.2023.1159856
_version_ 1785033181350592512
author Zhao, Tianming
Wu, Xu
Zhao, Xuelei
Yao, Kecheng
Li, Xiaojuan
Ni, Jixiang
author_facet Zhao, Tianming
Wu, Xu
Zhao, Xuelei
Yao, Kecheng
Li, Xiaojuan
Ni, Jixiang
author_sort Zhao, Tianming
collection PubMed
description BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a chronic progressive interstitial lung disease with limited therapeutic options. Recent studies have demonstrated that chemokines play a vital role in IPF pathogenesis. In the present study, we explored whether the gene signature associated with chemokines could be used as a reliable biological marker for patients with IPF. METHODS: Chemokine-related differentially expressed genes (CR-DEGs) in IPF and control lung tissue samples were identified using data from the Gene Expression Omnibus database. A chemokine-related signature of the diagnostic model was established using the LASSO-Cox regression. In addition, unsupervised cluster analysis was conducted using consensus-clustering algorithms. The CIBERSORT algorithm was used to calculate immune cell infiltration across patient subgroups. Finally, we established a mouse model of bleomycin-induced pulmonary fibrosis and a model of fibroblasts treated with TGFβ1. Expression levels of chemokine-related signature genes were determined using real-time quantitative polymerase chain reaction (RT-qPCR). RESULTS: We established a chemokine-related eleven-gene signature of a diagnostic model consisting of CXCL2, CCRL2, ARRB1, XCL1, GRK5, PPBP, CCL19, CCL13, CCL11, CXCL6, and CXCL13, which could easily distinguish between IPF patients and controls. Additionally, we identified two subtypes of IPF samples based on chemokine-related gene expression. Pulmonary function parameters and stromal scores were significantly higher in subtype 1 than in subtype 2. Several immune cell types, especially plasma cells and macrophages, differ significantly between the two subtypes. RT-qPCR results showed that the expression levels of Cxcl2 and Ccl2 increased considerably in bleomycin-induced mice. Meanwhile, Arrb1, Ccrl2, Grk5, and Ppbp expression was significantly reduced. Furthermore, multiple chemokine-related genes were altered in TGFβ1 or TNFα-induced fibroblast cells. CONCLUSIONS: A novel chemokine-related eleven-signature of diagnostic model was developed. These genes are potential biomarkers of IPF and may play essential roles in its pathogenesis.
format Online
Article
Text
id pubmed-10140527
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-101405272023-04-29 Identification and validation of chemokine system-related genes in idiopathic pulmonary fibrosis Zhao, Tianming Wu, Xu Zhao, Xuelei Yao, Kecheng Li, Xiaojuan Ni, Jixiang Front Immunol Immunology BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a chronic progressive interstitial lung disease with limited therapeutic options. Recent studies have demonstrated that chemokines play a vital role in IPF pathogenesis. In the present study, we explored whether the gene signature associated with chemokines could be used as a reliable biological marker for patients with IPF. METHODS: Chemokine-related differentially expressed genes (CR-DEGs) in IPF and control lung tissue samples were identified using data from the Gene Expression Omnibus database. A chemokine-related signature of the diagnostic model was established using the LASSO-Cox regression. In addition, unsupervised cluster analysis was conducted using consensus-clustering algorithms. The CIBERSORT algorithm was used to calculate immune cell infiltration across patient subgroups. Finally, we established a mouse model of bleomycin-induced pulmonary fibrosis and a model of fibroblasts treated with TGFβ1. Expression levels of chemokine-related signature genes were determined using real-time quantitative polymerase chain reaction (RT-qPCR). RESULTS: We established a chemokine-related eleven-gene signature of a diagnostic model consisting of CXCL2, CCRL2, ARRB1, XCL1, GRK5, PPBP, CCL19, CCL13, CCL11, CXCL6, and CXCL13, which could easily distinguish between IPF patients and controls. Additionally, we identified two subtypes of IPF samples based on chemokine-related gene expression. Pulmonary function parameters and stromal scores were significantly higher in subtype 1 than in subtype 2. Several immune cell types, especially plasma cells and macrophages, differ significantly between the two subtypes. RT-qPCR results showed that the expression levels of Cxcl2 and Ccl2 increased considerably in bleomycin-induced mice. Meanwhile, Arrb1, Ccrl2, Grk5, and Ppbp expression was significantly reduced. Furthermore, multiple chemokine-related genes were altered in TGFβ1 or TNFα-induced fibroblast cells. CONCLUSIONS: A novel chemokine-related eleven-signature of diagnostic model was developed. These genes are potential biomarkers of IPF and may play essential roles in its pathogenesis. Frontiers Media S.A. 2023-04-14 /pmc/articles/PMC10140527/ /pubmed/37122736 http://dx.doi.org/10.3389/fimmu.2023.1159856 Text en Copyright © 2023 Zhao, Wu, Zhao, Yao, Li and Ni https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Zhao, Tianming
Wu, Xu
Zhao, Xuelei
Yao, Kecheng
Li, Xiaojuan
Ni, Jixiang
Identification and validation of chemokine system-related genes in idiopathic pulmonary fibrosis
title Identification and validation of chemokine system-related genes in idiopathic pulmonary fibrosis
title_full Identification and validation of chemokine system-related genes in idiopathic pulmonary fibrosis
title_fullStr Identification and validation of chemokine system-related genes in idiopathic pulmonary fibrosis
title_full_unstemmed Identification and validation of chemokine system-related genes in idiopathic pulmonary fibrosis
title_short Identification and validation of chemokine system-related genes in idiopathic pulmonary fibrosis
title_sort identification and validation of chemokine system-related genes in idiopathic pulmonary fibrosis
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140527/
https://www.ncbi.nlm.nih.gov/pubmed/37122736
http://dx.doi.org/10.3389/fimmu.2023.1159856
work_keys_str_mv AT zhaotianming identificationandvalidationofchemokinesystemrelatedgenesinidiopathicpulmonaryfibrosis
AT wuxu identificationandvalidationofchemokinesystemrelatedgenesinidiopathicpulmonaryfibrosis
AT zhaoxuelei identificationandvalidationofchemokinesystemrelatedgenesinidiopathicpulmonaryfibrosis
AT yaokecheng identificationandvalidationofchemokinesystemrelatedgenesinidiopathicpulmonaryfibrosis
AT lixiaojuan identificationandvalidationofchemokinesystemrelatedgenesinidiopathicpulmonaryfibrosis
AT nijixiang identificationandvalidationofchemokinesystemrelatedgenesinidiopathicpulmonaryfibrosis